ArticleAnalytical chemistry2026
Detection of Aerosolized Protein Using a Condensation Growth Tube Coupled with an Electrochemical Immunoassay on Screen-Printed Carbon Electrodes.
Article in Analytical chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rapid point-of-need detection of aerosolized pathogens remains a critical need for environmental monitoring and infection control. Traditional filter-based bioaerosol collection methods are time-consuming and nonselective, capturing both infectious and noninfectious viral particles while causing mechanical damage through desiccation and mechanical stress. Furthermore, these approaches require laboratory-based nucleic acid extraction and amplification, which limits their utility for real-time monitoring. Here, we present an integrated aerosol-to-detection platform that couples a three-stage condensation growth tube (CGT) bioaerosol sampler with sensitive electrochemical immunodetection of the SARS-CoV-2 nucleocapsid (N) protein as a model virus antigen. The CGT gently concentrates aerosolized particles into a small liquid volume while preserving biological integrity through a water-based, low-velocity collection. Screen-printed carbon electrodes (SPCEs) were modified with capture antibodies and employed in a sandwich immunoassay format using horseradish peroxidase-linked detection antibodies and 3,3',5,5'-tetramethylbenzidine (TMB) as the electrochemical probe. The electrochemical immunoassay achieved a limit of detection (LOD) of 1.2 ng/mL for spiked N-protein solutions, demonstrating comparable sensitivity to published electrochemical biosensors for SARS-CoV-2 detection. The CGT successfully captured the aerosolized N protein with high efficiency across particle sizes of 50-100 nm with collection efficiency exceeding 95% for the target size range. Electrochemical detection of CGT-captured aerosolized N protein confirmed the successful combination of the sampling and sensing platform, providing average cathodic current signals distinguishable from blank controls. These results demonstrate the feasibility of coupling efficient bioaerosol collection to rapid electrochemical detection for point-of-need pathogen monitoring.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.